文献速递胃肠外科

早期胃癌淋巴管侵犯程度分层:单灶侵犯或可免追加胃切除术

Risk stratification by degree of lymphatic invasion in patients with early gastric cancer: additional gastrectomy might not be required.
PubMed 文献 · Surg Endosc · 2025-12-05

该回顾性研究分析了2000至2024年间5032例接受ESD的早期胃癌患者,其中420例有淋巴管侵犯程度数据,347例追加胃切除者按Ly-s(单灶)、Ly-i(2-3灶)、Ly-m(>3灶)分组分析淋巴结转移。Ly-s组无淋巴结转移,Ly-i和Ly-m组分别有7.8%和19.6%发生转移,Ly-m与淋巴结转移显著相关(OR 28.09)。Ly-s观察组无复发,Ly-m观察组复发多于手术组。

要点

  • 单灶淋巴管侵犯(Ly-s)患者淋巴结转移率为0,追加胃切除或可避免。
  • Ly-i和Ly-m组淋巴结转移率分别为7.8%和19.6%,Ly-m与转移显著相关。
  • Ly-m观察组5年无病生存率60.3%显著低于手术组99.1%。

核心结论

  • 单灶淋巴管侵犯的早期胃癌患者未见淋巴结转移,追加胃切除可能不必要。
  • Ly-m(>3灶)与淋巴结转移显著相关(OR 28.09,95%CI 1.95-405.32,P=0.014)。

研究设计与样本

  • 回顾性分析2000年1月至2024年1月在Samsung Medical Center接受ESD的5032例患者。
  • 420例有淋巴管侵犯程度数据,347例追加胃切除者的淋巴结转移按Ly-s、Ly-i、Ly-m三组分析。

主要发现

  • Ly-s组无淋巴结转移;Ly-i组11/141例(7.8%);Ly-m组22/112例(19.6%)。
  • Ly-s观察组无复发;Ly-i观察组5年无病生存率81.4% vs 手术组99.3%(P=0.144)。
  • Ly-m观察组5年无病生存率60.3% vs 手术组99.1%(P=0.012)。

关键数值与推荐

  • 淋巴管侵犯程度分为Ly-s(单灶)、Ly-i(2-3灶)、Ly-m(>3灶)。
  • Ly-m vs Ly-s的淋巴结转移OR为28.09(95%CI 1.95-405.32,P=0.014)。

临床怎么用

  • ESD标本病理应报告淋巴管侵犯灶数,辅助筛选可免追加手术的单灶侵犯患者。
  • Ly-m患者淋巴结转移风险高,追加胃切除可能获益,需个体化决策。

局限性

  • 回顾性单中心研究,样本量有限(347例追加手术)。
  • 淋巴管侵犯评估标准需进一步标准化,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lymphatic invasion (LI) is a significant risk factor for lymph node metastasis (LNM) following endoscopic submucosal dissection (ESD). Nevertheless, only some cases of early gastric cancer with LI exhibit LNM. This study aimed to compare the incidence of LNM based on the degree of LI. METHODS: A retrospective analysis was conducted on 5032 patients who underwent ESD at Samsung Medical Center between January 2000 and January 2024. A total of 420 patients had specific data on the degree of LI in ESD specimens. LNM of 347 patients who underwent additional gastrectomy (AG) was analyzed according to the categorized three groups: Ly-s (LI in a single focus), Ly-i (two or three foci), and Ly-m (more than three foci). RESULTS: The Ly-s patients exhibited no LNM, whereas Ly-i and Ly-m demonstrated LNM in 11 cases (11/141, 7.8%) and 22 cases (22/112, 19.6%). Multivariable analysis revealed that Ly-m was significantly associated with LNM (ref, Ly-s; Ly-m, OR 28.09, 95% CI 1.95 - 405.32, P = 0.014). Survival analysis indicated no recurrences in the observation group of Ly-s, while the Ly-i and Ly-m observation groups experienced more recurrences than the treated (AG) groups (5-year disease-free survival; Ly-i: AG 99.3% vs. observation 81.4%, P = 0.144 and Ly-m: AG 99.1% vs. observation 60.3%, P = 0.012). CONCLUSIONS: The absence of LNM in patients with a single focus of LI suggests that AG might be unnecessary in these cases. Further standardization of LI assessment criteria and larger sample sizes are needed to confirm these findings.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Min SK, Oh SE, An JY, et al. Risk stratification by degree of lymphatic invasion in patients with early gastric cancer: additional gastrectomy might not be required. Surg Endosc. 2025. PMID: 41350786. doi:10.1007/s00464-025-12451-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。